1. Crabtree JS, Kilbourne EJ, Peano BJ, Chippari S, Kenney T, McNally C, et al. A mouse model of androgenetic alopecia. Endocrinology. 2010;151(5):2373–80.
2. Sadick NS, Callender VD, Kircik LH, Kogan S. New Insight into the pathophysiology of hair loss trigger a paradigm shift in the treatment approach. J Drugs Dermatol. 2017;16(11):135–40.
3. Christoph T, Müller-Röver S, Audring H, Tobin DJ, Hermes B, Cotsarelis G, et al. The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol. 2000;142(5):862–73.
4. Rogaine® minoxidil topical 2% solution [Internet]. Government of Canada. 2017 [cited 2018 Sep 18]. Available from:
https://pdf.hres.ca/dpd_pm/00040937.pdf
.
5. Men’s Rogaine [Internet]. Drugs@FDA: FDA Approved Drug Products. 2006 [cited 2018 Sept 18]. Available from:
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021812s000LBL.pdf
.